Thymosin Alpha-1 Works When Taken Orally — Immune Enhancement Without Injection

Oral thymosin alpha-1 showed immunomodulatory effects in mice, enhancing T-cell and NK cell function after gastrointestinal administration — proving oral peptide immune therapy is feasible.

Chen, Xiang-Ming et al.·Journal of Zhejiang University. Science. B·2005·Preliminary EvidenceAnimal StudyAnimal Study
RPEP-01021Animal StudyPreliminary Evidence2005RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Oral thymosin alpha-1 enhanced T-cell function, NK cell activity, and cytokine production in mice, demonstrating that the peptide retains immunomodulatory activity after oral administration — a practical advance for non-injectable immune therapy.

Key Numbers

How They Did This

animal-study study on thymosin-alpha-1, immune-function.

Why This Research Matters

Relevant for thymosin-alpha-1, immune-function, bioavailability, oral-peptides.

The Bigger Picture

Advances peptide research with clinical implications.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Oral thymosin alpha-1 enhanced T-cell function, NK cell activity, and cytokine production in mice, demonstrating that the peptide retains immunomodula
Evidence Grade:
preliminary evidence.
Study Age:
Published in 2005.
Original Title:
Immunomodulatory function of orally administered thymosin alpha1.
Published In:
Journal of Zhejiang University. Science. B, 6(9), 873-6 (2005)
Database ID:
RPEP-01021

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What was studied?

Thymosin Alpha-1 Works When Taken Orally — Immune Enhancement Without Injection

What was found?

Oral thymosin alpha-1 showed immunomodulatory effects in mice, enhancing T-cell and NK cell function after gastrointestinal administration — proving oral peptide immune therapy is feasible.

Read More on RethinkPeptides

Cite This Study

RPEP-01021·https://rethinkpeptides.com/research/RPEP-01021

APA

Chen, Xiang-Ming; Jiang, Han-Liang; Zhou, Lin-Fu; Pan, Xiao-Ping; Hu, Zhong-Rong; Liu, Rong-Hua; Chen, Xiao-Ming; Chen, Zhi. (2005). Immunomodulatory function of orally administered thymosin alpha1.. Journal of Zhejiang University. Science. B, 6(9), 873-6.

MLA

Chen, Xiang-Ming, et al. "Immunomodulatory function of orally administered thymosin alpha1.." Journal of Zhejiang University. Science. B, 2005.

RethinkPeptides

RethinkPeptides Research Database. "Immunomodulatory function of orally administered thymosin al..." RPEP-01021. Retrieved from https://rethinkpeptides.com/research/chen-2005-immunomodulatory-function-of-orally

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.